We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+0.63%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.11B
AUM Growth
+$207M
Cap. Flow
+$183M
Cap. Flow %
2.99%
Top 10 Hldgs %
49.09%
Holding
188
New
51
Increased
37
Reduced
33
Closed
43

Top Buys

Rank Stock Value
1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$72.8M
2
AZO icon
AutoZone
AZO
+$70.8M
3
CROX icon
Crocs
CROX
+$61M
4
ULTA icon
Ulta Beauty
ULTA
+$58.5M
5
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$51.8M

Top Sells

Rank Stock Value
1
FIVE icon
Five Below
FIVE
+$67.4M
2
PTCT icon
PTC Therapeutics
PTCT
+$64.3M
3
ENTA icon
Enanta Pharmaceuticals
ENTA
+$61.2M
4
BURL icon
Burlington
BURL
+$60.4M
5
ROST icon
Ross Stores
ROST
+$42.3M

Sector Composition

Rank Sector Weight
1 Healthcare 42.67%
2 Consumer Discretionary 7.86%
3 Consumer Staples 7.27%
4 Technology 5.96%
5 Communication Services 1.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$1.33B 21.76%
28,000
– –
IWM icon
2
PUT
iShares Russell 2000 ETF
IWM
$80.9B
$667M 10.92%
30,000
– –
INCY icon
3
Incyte
INCY
$23.5B
$158M 2.59%
2,156,000
-216,000
-9% -$14.6M
BMY icon
4
Bristol-Myers Squibb
BMY
$127B
$145M 2.37%
2,324,000
-32,000
-1% -$1.88M
TVTX icon
5
Travere Therapeutics
TVTX
$5.33B
$127M 2.07%
4,078,000
-670,000
-14% -$18.9M
MRTX
6
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$123M 2.01%
836,000
+126,000
+18% +$19.6M
SUPN icon
7
Supernus Pharmaceuticals
SUPN
$2.68B
$121M 1.97%
4,136,000
+236,000
+6% +$7.16M
JAZZ icon
8
Jazz Pharmaceuticals
JAZZ
$15.9B
$112M 1.83%
878,000
+554,000
+171% +$72.8M
BIIB icon
9
Biogen
BIIB
$29.9B
$110M 1.81%
460,000
+88,000
+24% +$22.6M
VRTX icon
10
Vertex Pharmaceuticals
VRTX
$121B
$107M 1.75%
488,000
-148,000
-23% -$28.8M
MDGL icon
11
Madrigal Pharmaceuticals
MDGL
$12.6B
$95.2M 1.56%
1,124,000
+88,000
+8% +$7.23M
WMT icon
12
Walmart Inc
WMT
$871B
$82.6M 1.35%
1,711,854
+600,825
+54% +$28.7M
AZO icon
13
AutoZone
AZO
$48.3B
$79.7M 1.3%
+38,024
New +$70.8M
ENTA icon
14
Enanta Pharmaceuticals
ENTA
$372M
$79M 1.29%
1,056,000
-780,000
-42% -$61.2M
PCRX icon
15
Pacira BioSciences
PCRX
$1.02B
$78.9M 1.29%
1,312,000
+376,000
+40% +$20.7M
AVTX icon
16
Avalo Therapeutics
AVTX
$976M
$76.5M 1.25%
15,625
– –
ALKS icon
17
Alkermes
ALKS
$8.82B
$73.8M 1.21%
3,172,000
+816,000
+35% +$21.5M
MDT icon
18
Medtronic
MDT
$107B
$73.7M 1.21%
712,000
+262,000
+58% +$30.3M
REGN icon
19
Regeneron Pharmaceuticals
REGN
$68.8B
$73.3M 1.2%
116,000
+16,000
+16% +$9.84M
CRSP icon
20
CRISPR Therapeutics
CRSP
$4.58B
$67.6M 1.11%
892,000
+512,000
+135% +$44.7M
ASO icon
21
Academy Sports + Outdoors
ASO
$2.89B
$66.3M 1.08%
1,510,086
+114,376
+8% +$4.97M
ARGX icon
22
argenx
ARGX
$57.4B
$65.8M 1.08%
188,000
-20,000
-10% -$6.08M
CPRX
23
DELISTED
Catalyst Pharmaceutical
CPRX
$64.8M 1.06%
9,572,000
-428,000
-4% -$2.81M
BHVN
24
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$64.5M 1.06%
468,000
+92,000
+24% +$11.7M
ULTA icon
25
Ulta Beauty
ULTA
$20.4B
$62.1M 1.02%
+150,639
New +$58.5M
1
2 3 4 5

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DWM
Diversify Wealth Management Sandy, Utah $5.61B AUM 19.63% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
AIM
Alphinity Investment Management Sydney, Australia $5.68B AUM 26.72% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return

Armistice Capital's Q4 2021 Portfolio in Review

As of Q4 2021, Armistice Capital held 188 positions worth $6.11B, up 3.5% from $5.9B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Armistice Capital's Q4 2021 filing shows 51 new, 37 increased, 33 reduced and 43 closed positions. Its largest new stake was AutoZone: 38,024 shares worth $79.7M. The largest sale was Five Below, an estimated $67.4M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 45% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

  • Armistice Capital's largest Q4 2021 buy was AutoZone: 38,024 shares worth $79.7M.
  • Armistice Capital added most to Jazz Pharmaceuticals in Q4 2021, an estimated $72.8M increase.
  • Armistice Capital's biggest Q4 2021 reduction was PTC Therapeutics, cutting an estimated $64.3M.
  • Armistice Capital fully exited Five Below in Q4 2021, selling an estimated $67.4M.
  • Armistice Capital's ten largest holdings make up 49% of its $6.11B portfolio in Q4 2021.
  • Armistice Capital opened 51 new positions and closed 43 in Q4 2021.
  • Armistice Capital's portfolio value rose 3.5% quarter-over-quarter to $6.11B.

Based on Armistice Capital's 13F filing for Q4 2021, filed 14 Feb 2022.